FR2928149B1 - Composes derives d'azetidines, leur preparation et leur application en therapeutique - Google Patents

Composes derives d'azetidines, leur preparation et leur application en therapeutique

Info

Publication number: FR2928149B1
Authority: FR; France
Prior art keywords: azetidine; preparation; therapeutic use; derived compounds; derived
Prior art date: 2008-02-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0801117A

Other languages

English (en)

Other versions

FR2928149A1 (fr

Inventor

Florian Auger

Patrick Bernardelli

Luc Even

Jean Francois Sabuco

Corinne Terrier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Aventis France

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-29

Filing date

2008-02-29

Publication date

2011-01-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39745128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2928149(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-29 Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France

2008-02-29 Priority to FR0801117A priority Critical patent/FR2928149B1/fr

2009-02-26 Priority to TW098106237A priority patent/TW200940503A/zh

2009-02-26 Priority to PE2009000286A priority patent/PE20091431A1/es

2009-02-26 Priority to ARP090100656A priority patent/AR070485A1/es

2009-02-27 Priority to CA2716961A priority patent/CA2716961A1/fr

2009-02-27 Priority to PCT/FR2009/000214 priority patent/WO2009118473A2/fr

2009-02-27 Priority to CL2009000464A priority patent/CL2009000464A1/es

2009-02-27 Priority to AU2009229026A priority patent/AU2009229026A1/en

2009-02-27 Priority to UY031682A priority patent/UY31682A1/es

2009-02-27 Priority to EA201071012A priority patent/EA201071012A1/ru

2009-02-27 Priority to MX2010009512A priority patent/MX2010009512A/es

2009-02-27 Priority to BRPI0908336-7A priority patent/BRPI0908336A2/pt

2009-02-27 Priority to KR1020107019131A priority patent/KR20100122489A/ko

2009-02-27 Priority to CN2009801069919A priority patent/CN101959855A/zh

2009-02-27 Priority to EP09724410A priority patent/EP2254862A2/fr

2009-02-27 Priority to JP2010548143A priority patent/JP2011513285A/ja

2009-09-04 Publication of FR2928149A1 publication Critical patent/FR2928149A1/fr

2010-08-19 Priority to CO10102306A priority patent/CO6251235A2/es

2010-08-25 Priority to IL207799A priority patent/IL207799A0/en

2010-08-26 Priority to US12/869,281 priority patent/US20110053908A1/en

2010-09-13 Priority to MA33175A priority patent/MA32192B1/fr

2011-01-14 Publication of FR2928149B1 publication Critical patent/FR2928149B1/fr

2011-01-14 Application granted granted Critical

Status Expired - Fee Related legal-status Critical Current

2028-02-29 Anticipated expiration legal-status Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Obesity (AREA)
Hematology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)

FR0801117A 2008-02-29 2008-02-29 Composes derives d'azetidines, leur preparation et leur application en therapeutique Expired - Fee Related FR2928149B1 (fr)

Priority Applications (20)

Application Number	Priority Date	Filing Date	Title
FR0801117A FR2928149B1 (fr)	2008-02-29	2008-02-29	Composes derives d'azetidines, leur preparation et leur application en therapeutique
TW098106237A TW200940503A (en)	2008-02-29	2009-02-26	Compounds derived from azetidines, their preparation and their therapeutic application
PE2009000286A PE20091431A1 (es)	2008-02-29	2009-02-26	Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
ARP090100656A AR070485A1 (es)	2008-02-29	2009-02-26	Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
MX2010009512A MX2010009512A (es)	2008-02-29	2009-02-27	Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica.
JP2010548143A JP2011513285A (ja)	2008-02-29	2009-02-27	アゼチジン誘導化合物、この調製方法および該化合物の治療的使用
CL2009000464A CL2009000464A1 (es)	2008-02-29	2009-02-27	Compuestos derivados de 3-(n-(azetidin-3-il)metanosulfonilamino)benzamida, actuan en los receptores cannabinoides cb1; procedimiento para prepararlos; composici0n farmaceutica y su uso para tratar o prevenir trastornos psiquiatricos, trastornos cognitivos, enfermedades neurodegenerativas, trastornos del metabolismo, dolor.
AU2009229026A AU2009229026A1 (en)	2008-02-29	2009-02-27	Azetidine-derived compounds, preparation method therefor and therapeutic use of same
UY031682A UY31682A1 (es)	2008-02-29	2009-02-27	Compuestos derivados de azetetidinas, su preparacion y su aplicacion en terapeutica
EA201071012A EA201071012A1 (ru)	2008-02-29	2009-02-27	Производные азетидинов, способ их получения и применение их в терапии
CA2716961A CA2716961A1 (fr)	2008-02-29	2009-02-27	Composes derives d'azetidines, leur preparation et leur application en therapeutique
BRPI0908336-7A BRPI0908336A2 (pt)	2008-02-29	2009-02-27	Compostos derivados de azetidinas, o respectivo preparo e a respectiva aplicação em terapêutica, medicamentos e composições farmacêuticas compreendendo os mesmos
KR1020107019131A KR20100122489A (ko)	2008-02-29	2009-02-27	아제티딘-유도 화합물, 그의 제조 방법 및 그의 치료학적 용도
CN2009801069919A CN101959855A (zh)	2008-02-29	2009-02-27	氮杂环丁烷衍生化合物、其制备方法和其治疗用途
EP09724410A EP2254862A2 (fr)	2008-02-29	2009-02-27	Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
PCT/FR2009/000214 WO2009118473A2 (fr)	2008-02-29	2009-02-27	Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
CO10102306A CO6251235A2 (es)	2008-02-29	2010-08-19	Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
IL207799A IL207799A0 (en)	2008-02-29	2010-08-25	Azetidine-derived compounds, preparation method therefor and therapeutic use of same
US12/869,281 US20110053908A1 (en)	2008-02-29	2010-08-26	Azetidine-derived compounds, preparation method therefor and therapeutic use of same
MA33175A MA32192B1 (fr)	2008-02-29	2010-09-13	Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0801117A FR2928149B1 (fr)	2008-02-29	2008-02-29	Composes derives d'azetidines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number	Publication Date
FR2928149A1 FR2928149A1 (fr)	2009-09-04
FR2928149B1 true FR2928149B1 (fr)	2011-01-14

Family

ID=39745128

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0801117A Expired - Fee Related FR2928149B1 (fr)	2008-02-29	2008-02-29	Composes derives d'azetidines, leur preparation et leur application en therapeutique

Country Status (20)

Country	Link
US (1)	US20110053908A1 (fr)
EP (1)	EP2254862A2 (fr)
JP (1)	JP2011513285A (fr)
KR (1)	KR20100122489A (fr)
CN (1)	CN101959855A (fr)
AR (1)	AR070485A1 (fr)
AU (1)	AU2009229026A1 (fr)
BR (1)	BRPI0908336A2 (fr)
CA (1)	CA2716961A1 (fr)
CL (1)	CL2009000464A1 (fr)
CO (1)	CO6251235A2 (fr)
EA (1)	EA201071012A1 (fr)
FR (1)	FR2928149B1 (fr)
IL (1)	IL207799A0 (fr)
MA (1)	MA32192B1 (fr)
MX (1)	MX2010009512A (fr)
PE (1)	PE20091431A1 (fr)
TW (1)	TW200940503A (fr)
UY (1)	UY31682A1 (fr)
WO (1)	WO2009118473A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2934995B1 (fr) *	2008-08-14	2010-08-27	Sanofi Aventis	Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2760862B1 (fr)	2011-09-27	2015-10-21	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
KR101426408B1 (ko) *	2013-02-19	2014-08-07	한국과학기술연구원	4각 고리 질소 화합물, 이를 포함하는 우울증, 정신 질환, 조루증, 또는 신경병증성 통증의 예방 또는 치료용 약학 조성물, 및 상기 약학 조성물을 포함하는 제제
GB201321601D0 (en) *	2013-12-06	2014-01-22	Canbex Therapeutics Ltd	Modulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355631B1 (en) *	2000-03-03	2002-03-12	Aventis Pharma S.A.	Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
US6479479B2 (en) *	2000-03-03	2002-11-12	Aventis Pharma S.A.	Azetidine derivatives, their preparation and pharmaceutical compositions containing them
FR2805817B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
US6566356B2 (en) *	2000-03-03	2003-05-20	Aventis Pharma S.A.	Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
US20030139386A1 (en) *	2001-12-21	2003-07-24	Sophie Cote	Pharmaceutical compositions based on azetidine derivatives
FR2833842B1 (fr)	2001-12-21	2004-02-13	Aventis Pharma Sa	Compositions pharmaceutiques a base de derives d'azetidine
RU2006133258A (ru) *	2004-02-17	2008-04-10	Лабораториос Дель Др. Эстеве С.А. (Es)	Замещенные азетидиновые производные, их получение и применение в качестве лекарственных средств

2008
- 2008-02-29 FR FR0801117A patent/FR2928149B1/fr not_active Expired - Fee Related
2009
- 2009-02-26 TW TW098106237A patent/TW200940503A/zh unknown
- 2009-02-26 PE PE2009000286A patent/PE20091431A1/es not_active Application Discontinuation
- 2009-02-26 AR ARP090100656A patent/AR070485A1/es unknown
- 2009-02-27 CN CN2009801069919A patent/CN101959855A/zh active Pending
- 2009-02-27 JP JP2010548143A patent/JP2011513285A/ja not_active Withdrawn
- 2009-02-27 AU AU2009229026A patent/AU2009229026A1/en not_active Abandoned
- 2009-02-27 CL CL2009000464A patent/CL2009000464A1/es unknown
- 2009-02-27 KR KR1020107019131A patent/KR20100122489A/ko not_active Application Discontinuation
- 2009-02-27 CA CA2716961A patent/CA2716961A1/fr not_active Abandoned
- 2009-02-27 MX MX2010009512A patent/MX2010009512A/es not_active Application Discontinuation
- 2009-02-27 EA EA201071012A patent/EA201071012A1/ru unknown
- 2009-02-27 WO PCT/FR2009/000214 patent/WO2009118473A2/fr active Application Filing
- 2009-02-27 EP EP09724410A patent/EP2254862A2/fr not_active Withdrawn
- 2009-02-27 BR BRPI0908336-7A patent/BRPI0908336A2/pt not_active IP Right Cessation
- 2009-02-27 UY UY031682A patent/UY31682A1/es not_active Application Discontinuation
2010
- 2010-08-19 CO CO10102306A patent/CO6251235A2/es not_active Application Discontinuation
- 2010-08-25 IL IL207799A patent/IL207799A0/en unknown
- 2010-08-26 US US12/869,281 patent/US20110053908A1/en not_active Abandoned
- 2010-09-13 MA MA33175A patent/MA32192B1/fr unknown

Also Published As

Publication number	Publication date
WO2009118473A2 (fr)	2009-10-01
US20110053908A1 (en)	2011-03-03
CN101959855A (zh)	2011-01-26
EP2254862A2 (fr)	2010-12-01
AR070485A1 (es)	2010-04-07
CL2009000464A1 (es)	2010-04-09
JP2011513285A (ja)	2011-04-28
EA201071012A1 (ru)	2011-04-29
AU2009229026A1 (en)	2009-10-01
MA32192B1 (fr)	2011-04-01
CO6251235A2 (es)	2011-02-21
UY31682A1 (es)	2009-09-30
WO2009118473A3 (fr)	2009-11-19
PE20091431A1 (es)	2009-10-19
IL207799A0 (en)	2010-12-30
CA2716961A1 (fr)	2009-10-01
BRPI0908336A2 (pt)	2015-08-04
KR20100122489A (ko)	2010-11-22
TW200940503A (en)	2009-10-01
FR2928149A1 (fr)	2009-09-04
MX2010009512A (es)	2010-12-15

Publication	Publication Date	Title
FR2928149B1 (fr)	2011-01-14	Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2911604B1 (fr)	2009-04-17	Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2910473B1 (fr)	2009-02-13	Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
FR2915199B1 (fr)	2010-01-22	Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2933700B1 (fr)	2010-07-30	Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2915198B1 (fr)	2009-12-18	Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2945534B1 (fr)	2012-11-16	DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2941696B1 (fr)	2011-04-15	Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2917412B1 (fr)	2009-08-21	Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2934265B1 (fr)	2010-07-30	Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
FR2934995B1 (fr)	2010-08-27	Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique
FR2915197B1 (fr)	2009-06-12	Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2920023B1 (fr)	2013-02-08	Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
FR2917413B1 (fr)	2009-08-21	Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2945533B1 (fr)	2011-05-27	Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2938537B1 (fr)	2012-10-26	Derives de carbamates d'alkyl-heterocycles, leur preparation et leur application en therapeutique.
FR2927625B1 (fr)	2010-03-12	Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2930249B1 (fr)	2010-05-14	Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
FR2892416B1 (fr)	2008-06-27	Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
FR2963005B1 (fr)	2012-08-17	Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
FR2940284B1 (fr)	2011-02-18	Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
FR2925901B1 (fr)	2011-03-04	DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2948369B1 (fr)	2013-04-12	Derives d'uree de tetrahydroquinoxaline, leur preparation et leur application en therapeutique
FR2902791B1 (fr)	2008-08-22	Derives d'urees de tropane,leur preparation et leur application en therapeutique
FR2925906B1 (fr)	2010-08-20	COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Legal Events

Date	Code	Title	Description
2012-11-23	ST	Notification of lapse	Effective date: 20121031